Systemax (SYX)
Systemax Performance
Historical performance is a good guide for the future, but it is imperfect. Pay attention to a company's history, but be realistic about what you can project into the future.
5 Year Total Returns Performance
Returns from price appreciation only give a partial view of the returns to an investor. This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested)
1 Year Total Returns Performance Comparison
Here are Systemax's total returns compared to the market and some of its peers. High historical total returns are excellent - especially if you held the stock at the time - but returns can change direction quickly. To predict future performance, looking at the business is more important than looking at historic returns.
- SYX Total Returns
- ^SPXTR Total Returns
- ACIW Total Returns
- ISNS Total Returns
| 1 month total returns | YTD total returns | 1 year total returns* | 3 year total returns | |
|---|---|---|---|---|
| SYX | -29.59% | -26.33% | -16.16% | 3.49% |
| ^SPXTR | -5.81% | 5.38% | 0.88% | 52.09% |
| ACIW | -4.64% | 33.34% | 22.48% | 147.2% |
| ISNS | -26.85% | -20.95% | -51.83% | -45.44% |
* May differ from chart if one year ago today was not a trading day. Table uses the previous trading day as a base while chart uses the next trading day.
Fundamental Performance
Price vs Earnings
In the long run, the price and earnings of a company are correlated. If the two metrics are diverging, there should be a good reason why. Divergence without reason can signal danger or opportunity.
Earnings Yield vs Dividend Yield
Yields show how much you are getting for the price you pay. For example, an earnings yield of 8% means that for every dollar you pay, you get 8 cents worth of current earnings. Take these numbers into account when buying to see if you are over-paying or getting a good deal.
Revenue and Earnings Growth
Revenues show how much the company is selling to customers, while net income is what remains for shareholders after the company pays its expenses. Revenue growth often persists over time, but net income is more fickle. Watch closely to see if revenue and income grow at similar rates.
Efficent Use of Assets
Profit margins show what percentage of every dollar of sales turns into earnings. Asset Uitlization shows how many dollars of sales a company gets for each dollar that the company invests in assets. Multiplying the two numbers together gives you Return on Assets which tells you approximately how efficiently the company invests money to earn more money.
Reinvestment Strategy
Return on Invested Capital (ROIC) tells you how much income a company earned after investing $1 in its business. The Payout Ratio tells what percentage of the company's income it pays to shareholders instead of reinvesting in its own growth. Watch out for companies that pay out very little when their ROIC is low.
You may also be interested in these SYX related companies
SYX News
about 31 days ago by earningscast
May 01, 4:35PM Wall St. Cheat Sheet
about 32 days ago by MarketBrief
Mar 13, 4:00PM Business Wire
Mar 08, 4:00PM Business Wire
about 93 days ago by earningscast
Feb 21, 4:00PM Business Wire
Nov 07, 10:00AM Business Wire
Oct 04, 9:02AM Business Wire
Sep 27, 4:00PM Business Wire
about 410 days ago by Street_Insider
about 522 days ago by redman59
about 567 days ago by ogfomk
about 660 days ago by OptionRadar
about 661 days ago by michaeljoseph
about 661 days ago by OptionRadar
about 751 days ago by ukdaytrader
about 751 days ago by ukdaytrader
about 751 days ago by ukdaytrader
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SYX | 12.16 | +0.16 | +1.33% | 436.80M |
| SYUT | 4.94 | -0.18 | -3.52% | 293.38M |
| SYT | 64.31 | -0.63 | -0.97% | 30.72B |
| SYSW | 1.25 | +0.05 | +4.17% | 57.98M |
| SYPR | 5.90 | +0.00 | +0.00% | 117.29M |
| SYNL | 11.70 | -0.06 | -0.49% | 74.43M |
| SYNA | 26.82 | +0.03 | +0.11% | 882.46M |
| SSS | 49.35 | +0.53 | +1.09% | 1.414B |
| SSRX | 12.49 | -0.06 | -0.48% | 269.45M |
| SSRI | 11.00 | -0.22 | -1.96% | 906.02M |
